7-Epiclindamycin hydrochloride
(2S,4R)-N-[(1S,2R)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride
Also Known As: 7-Epiclindamycin hydrochloride|7-Epiclindamycin HCl|7-Epi Clindamycin Hydrochloride|Clindamycin hydrochloride|Clindamycin BP Impurity C|Clindamycin EP Impurity C HCl|7-Deoxy-7(R)-chlorolincomycin hydrochloride|D-erythro-D-galacto-Octopyranoside, methyl 7-(S)-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, hydrochloride, trans-alpha-|(2S,4R)-N-[(1S,2R)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride|D-erythro-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride, (2S-trans)-|methyl 7-chloro-6,7,8-trideoxy-6-{[(4r)-1-methyl-4-propyl-l-prolyl]amino}-1-thio-d-erythro-|A-d-galacto-octopyranoside hydrochloride(1:1)|(2S,4R)-N-[(1S,2R)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride|D-erythro-a-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1); D-erythro-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, trans- a- (8CI); D-erythro-a-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, monohydrochloride, (2S-trans)-; D-erythro-a-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, monohydrochloride (9CI); 7-Deoxy-7(R)-chlorolincomycin hydrochloride; 7-Epi clindamycin hydrochloride; 7-Epiclindamycin hydrochloride; Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-a-D-galacto-octopyranoside hy|D-erythro-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1)|Methyl 7-chloro-6,7,8-trideoxy-6-({hydroxy[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]methylidene}amino)-1-thio-D-erythro-alpha-D-galacto-octopyranoside--hydrogen chloride (1/1)|Methyl 7-chloro-6,7,8-trideoxy-6-{[hydroxy(1-methyl-4-propylpyrrolidin-2-yl)methylidene]amino}-1-thiooctopyranoside--hydrogen chloride (1/1)
| Molecular Formula | C18H34Cl2N2O5S |
|---|---|
| Molecular Weight | 460.15656 g/mol |
| LogP | 0.81 |
| Topological Polar Surface Area | 102.26 Ų |
| Hydrogen Bond Donors | 4 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Exact Mass | 460.15656 |
| Heavy Atoms | 28 |
| Complexity | 502.6 |
Chemical Identifiers
| CAS Number | 17431-55-9 |
|---|---|
| SMILES | CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)Cl.Cl |
Product Overview
7-Epiclindamycin hydrochloride (CAS 17431-55-9), with molecular formula C18H34Cl2N2O5S and molecular weight 460.15656 g/mol. IUPAC: (2S,4R)-N-[(1S,2R)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride.
Frequently Asked Questions
📚 Academic Support
Scientific research papers and technical documentation supporting this product for informed procurement decisions.
Technical Blog Article
Multi-source research profile: chemical properties, regulatory status, and sourcing guide for 7-Epiclindamycin hydrochloride.
Browse Technical Blog →No research papers found for this product yet.
We continuously update our academic references. Check back soon!